TR200504091T2 - (7alfa,17alfa)-17-hidroksi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-on içeren yüksek saflıkta bileşim. - Google Patents

(7alfa,17alfa)-17-hidroksi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-on içeren yüksek saflıkta bileşim.

Info

Publication number
TR200504091T2
TR200504091T2 TR2005/04091T TR200504091T TR200504091T2 TR 200504091 T2 TR200504091 T2 TR 200504091T2 TR 2005/04091 T TR2005/04091 T TR 2005/04091T TR 200504091 T TR200504091 T TR 200504091T TR 200504091 T2 TR200504091 T2 TR 200504091T2
Authority
TR
Turkey
Prior art keywords
hydroxy
methyl
pregn
7alpha
17alpha
Prior art date
Application number
TR2005/04091T
Other languages
English (en)
Inventor
Huub Gerard Maria Kirchholtes Peter
Arnoud Jozef Maria Theresia Sas Gerard
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8234220&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200504091(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of TR200504091T2 publication Critical patent/TR200504091T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Abstract

Buluş yüksek saflıkta bir (7a,17a)-17-hidroksi-7-metıl-19-nor-17-5 pregn-5(10)-en-20-in-3-on bileşiminin hazırlaması için bir işlem ile ilgilidir. İşlem %0.5'ten daha az (7a,17a)-17-hidroksi-7-metıl-19-nor-17-p egn-4-en-20-in-3-on'luk bir bileşim sağlamaktadır. Bu bileşim kararlı farmasotik dozaj birimlerinin hazırlamasında bir kaynak olarak kullanılabilmektedir.
TR2005/04091T 1998-10-16 1999-10-11 (7alfa,17alfa)-17-hidroksi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-on içeren yüksek saflıkta bileşim. TR200504091T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98203460 1998-10-16

Publications (1)

Publication Number Publication Date
TR200504091T2 true TR200504091T2 (tr) 2006-05-22

Family

ID=8234220

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2001/01083T TR200101083T2 (tr) 1998-10-16 1999-10-11 (7alfa,17alfa)-17-hidroksi- 7-metil-19-nor-17-pregn-5 (10)-en-20-in-3-on içeren yüksek saflıkta bileşim.
TR2005/04091T TR200504091T2 (tr) 1998-10-16 1999-10-11 (7alfa,17alfa)-17-hidroksi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-on içeren yüksek saflıkta bileşim.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2001/01083T TR200101083T2 (tr) 1998-10-16 1999-10-11 (7alfa,17alfa)-17-hidroksi- 7-metil-19-nor-17-pregn-5 (10)-en-20-in-3-on içeren yüksek saflıkta bileşim.

Country Status (30)

Country Link
US (3) US6969708B1 (tr)
EP (2) EP1275379A3 (tr)
JP (1) JP2002527525A (tr)
KR (3) KR20050003358A (tr)
CN (2) CN100432093C (tr)
AR (1) AR020832A1 (tr)
AT (1) ATE239032T1 (tr)
AU (1) AU763232B2 (tr)
BR (1) BR9914441A (tr)
CA (1) CA2344686C (tr)
CO (1) CO5160271A1 (tr)
CZ (1) CZ298703B6 (tr)
DE (1) DE69907495T2 (tr)
DK (1) DK1121375T3 (tr)
ES (1) ES2197677T3 (tr)
HK (1) HK1039620B (tr)
HU (1) HUP0104206A3 (tr)
ID (1) ID28463A (tr)
IL (1) IL141850A (tr)
NO (1) NO317427B1 (tr)
NZ (1) NZ510501A (tr)
PE (1) PE20001377A1 (tr)
PL (1) PL197870B1 (tr)
PT (1) PT1121375E (tr)
RU (1) RU2220975C2 (tr)
SK (1) SK284569B6 (tr)
TR (2) TR200101083T2 (tr)
TW (2) TW200403251A (tr)
WO (1) WO2000023460A1 (tr)
ZA (1) ZA200101952B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL356465A1 (en) * 2002-10-04 2004-04-05 ANPHARM Przedsiębiorstwo Farmaceutyczne S.A. METHOD OF MANUFACTURE OF 17beta-HYDROXY-7alpha-METHYL-19-NOR-17alpha-PREGN-5(10)-ENE-20-YNE-3-ONE
TW200418525A (en) * 2002-11-20 2004-10-01 Akzo Nobel Nv Coated pharmaceutical tablets containing Tibolone
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
WO2005117899A1 (en) * 2004-06-02 2005-12-15 Cipla Limited Pharmaceutical composition comprising tibolone and process for procuding the same
PL1848727T3 (pl) 2005-02-01 2015-11-30 Hoffmann La Roche Polimorf b ibandronianu
CN101111504B (zh) * 2005-02-01 2011-12-21 霍夫曼-拉罗奇有限公司 伊班膦酸盐多晶型物a
WO2006125453A1 (en) * 2005-05-23 2006-11-30 Newchem S.P.A. Process for the preparation of pure crystalline tibolone
CZ300465B6 (cs) * 2007-07-25 2009-05-27 Zentiva, A. S. Zpusob výroby komprimované farmaceutické formulace s obsahem tibolonu
ITMI20130120A1 (it) * 2013-01-25 2014-07-26 Ind Chimica Srl Processo per la preparazione in forma cristallina di tibolone, (7alfa,17alfa)-17-idrossi-7-metil-19-norpregn-5(10)-en-20-in-3-one
US20220046948A1 (en) * 2018-12-17 2022-02-17 Aimmune Therapeutics, Inc. Formulations for egg oral immunotherapy, methods of manufacture, and treatments for egg allergy
CN114409717B (zh) * 2021-12-17 2023-03-17 湖南科益新生物医药有限公司 替勃龙中间体醚化物和替勃龙的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665514A (tr) * 1964-06-16
CH488682A (de) 1965-07-30 1970-04-15 Ciba Geigy Verfahren zur Herstellung von 4,9,11-Trienen der 19-Nor-androstanreihe
NL146838B (nl) 1966-06-24 1975-08-15 Organon Nv Werkwijze voor het bereiden van (delta)5(10)-3- keto-19-norsteroiden.
US3515719A (en) 1967-03-15 1970-06-02 Upjohn Co 7-methyl-6,19-epoxy steroids of the androstane series
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
JPH03503414A (ja) 1988-03-25 1991-08-01 アクゾ・エヌ・ヴエー フッ化物塩を含有する医薬製剤
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
ES2134313T3 (es) 1993-03-05 1999-10-01 Akzo Nobel Nv Utilizacion de derivados de pregnano para el tratamiento de tumores.
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation
TW448049B (en) 1997-03-05 2001-08-01 Akzo Nobel Nv Use of a 7Α-methyl-17Α-ethynyl-estrane derivative for the treatment of atherosclerosis
IL123984A (en) * 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable

Also Published As

Publication number Publication date
ES2197677T3 (es) 2004-01-01
SK4932001A3 (en) 2001-12-03
EP1275379A2 (en) 2003-01-15
CZ2001976A3 (cs) 2001-08-15
CA2344686C (en) 2009-04-28
TW200403251A (en) 2004-03-01
DK1121375T3 (da) 2003-08-04
AU763232B2 (en) 2003-07-17
PE20001377A1 (es) 2000-12-09
TR200101083T2 (tr) 2001-08-21
IL141850A0 (en) 2002-03-10
US20040248870A1 (en) 2004-12-09
CO5160271A1 (es) 2002-05-30
HUP0104206A3 (en) 2002-06-28
CN1322210A (zh) 2001-11-14
KR20050003358A (ko) 2005-01-10
WO2000023460A1 (en) 2000-04-27
NO317427B1 (no) 2004-10-25
CZ298703B6 (cs) 2007-12-27
DE69907495D1 (de) 2003-06-05
HK1039620B (zh) 2003-08-22
EP1121375A1 (en) 2001-08-08
AU6202999A (en) 2000-05-08
NO20011664D0 (no) 2001-04-03
BR9914441A (pt) 2001-06-26
PL197870B1 (pl) 2008-05-30
CN100378116C (zh) 2008-04-02
EP1121375B1 (en) 2003-05-02
NZ510501A (en) 2003-10-31
AR020832A1 (es) 2002-05-29
HUP0104206A2 (hu) 2002-04-29
JP2002527525A (ja) 2002-08-27
RU2220975C2 (ru) 2004-01-10
DE69907495T2 (de) 2004-05-06
HK1039620A1 (en) 2002-05-03
NO20011664L (no) 2001-04-03
CA2344686A1 (en) 2000-04-27
CN100432093C (zh) 2008-11-12
TW577893B (en) 2004-03-01
EP1275379A3 (en) 2003-03-26
KR100635018B1 (ko) 2006-10-17
US20050245496A1 (en) 2005-11-03
ATE239032T1 (de) 2003-05-15
KR20060071897A (ko) 2006-06-27
SK284569B6 (sk) 2005-06-02
US6969708B1 (en) 2005-11-29
ZA200101952B (en) 2002-06-10
CN1769293A (zh) 2006-05-10
KR20010080133A (ko) 2001-08-22
IL141850A (en) 2005-11-20
PT1121375E (pt) 2003-07-31
PL347264A1 (en) 2002-03-25
ID28463A (id) 2001-05-24

Similar Documents

Publication Publication Date Title
TR200102800T2 (tr) Yeni bileşikler.
DE69830504D1 (de) Antithrombotische mitteln
TR200400238T4 (tr) ''Perindopril tert-bütilamin tuzunun alfa kristalin şekli''
DE69831868D1 (en) Antithrombosemittel
TR200100299T2 (tr) Tedavi edici biaril türevleri.
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
TR199901578T2 (tr) Klaritromisin form 0 kristali
PT1075259E (pt) Novos analogos gordos para o tratamento de diabetes
EA199900937A1 (ru) Фармацевтические композиции, содержащие вориконазол
CY1107899T1 (el) 6.αλφα., 9.αλφα. - διφθορο-17.αλφα.-(2-φουρανυλοανθρακοξυλικο) οξυ-11.βητα.-υδροξυ-16.αλφα.-μεθυλο-3-οξο-ανδροστα-1,4-διενιο-17-ανθρακοθειϊκο οξυ s-φθορομεθυλο εστερας ως αντιφλεγμονωδης παραγοντας
ES2137998T3 (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
ATE273305T1 (de) Thrombin-inhibitoren
TR200504091T2 (tr) (7alfa,17alfa)-17-hidroksi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-on içeren yüksek saflıkta bileşim.
SE9804212D0 (sv) Compounds
EA200400708A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
TR200002506T2 (tr) S ile ikame edilmiş 11beta-benzaldoksim-estra-4,9-dien-karbonik asit tiolesterler, üretimleri için yöntem ve bu bileşimleri içeren farmasötik terkipler.
BR9713207A (pt) Derivados de 3-mercaptoacetilamino-1,5-substituìdo-2-oxo-azepan uteis como inibidores de metaloproteinase de matriz
PL328225A1 (en) Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors
IT1307786B1 (it) Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.
HUP0302880A2 (hu) Egy ciklusos depszipeptid javított aktivitással rendelkező kristályos formáját tartalmazó gyógyászati készítmények
AU2002218422A1 (en) New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
BR9811954A (pt) ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias
TR199800210T2 (tr) Didepsipeptid temelli endoparazitisid kompozisyonlar, yeni didepsipeptidler ve bunlarin üretimi için islemler.
ID27440A (id) Proses untuk menyiapkan penengah-penengah